Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
Lilly filed six new lawsuits against U.S. entities selling illegal retatrutide and referred more than 200 bad actors to regulators and law enforcement worldwide. The company reported over 14,000 websites, ads, and social media posts in more than 100 countries that unlawfully market the unapproved drug to internet platforms.
Key figures
- Lawsuits filed
- 6
- Regulatory referrals
- > 200
- Countries with listings
- > 100
- Reported illegal listings
- > 14,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.